JP2014502628A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014502628A5 JP2014502628A5 JP2013548903A JP2013548903A JP2014502628A5 JP 2014502628 A5 JP2014502628 A5 JP 2014502628A5 JP 2013548903 A JP2013548903 A JP 2013548903A JP 2013548903 A JP2013548903 A JP 2013548903A JP 2014502628 A5 JP2014502628 A5 JP 2014502628A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- million
- dose
- cell
- million cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11250025 | 2011-01-12 | ||
| EP11250025.1 | 2011-01-12 | ||
| PCT/IB2012/000097 WO2012095743A2 (en) | 2011-01-12 | 2012-01-12 | Methods and compositions for use in intralymphatic cellular therapies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016190665A Division JP2017035094A (ja) | 2011-01-12 | 2016-09-29 | 自己免疫および炎症性疾患におけるリンパ系内投与用の脂肪由来間葉系幹細胞 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014502628A JP2014502628A (ja) | 2014-02-03 |
| JP2014502628A5 true JP2014502628A5 (enExample) | 2015-03-05 |
| JP6018081B2 JP6018081B2 (ja) | 2016-11-02 |
Family
ID=45558792
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013548903A Expired - Fee Related JP6018081B2 (ja) | 2011-01-12 | 2012-01-12 | 自己免疫および炎症性疾患におけるリンパ系内投与用の脂肪由来間葉系幹細胞 |
| JP2016190665A Pending JP2017035094A (ja) | 2011-01-12 | 2016-09-29 | 自己免疫および炎症性疾患におけるリンパ系内投与用の脂肪由来間葉系幹細胞 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016190665A Pending JP2017035094A (ja) | 2011-01-12 | 2016-09-29 | 自己免疫および炎症性疾患におけるリンパ系内投与用の脂肪由来間葉系幹細胞 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20140154274A1 (enExample) |
| EP (1) | EP2663316A2 (enExample) |
| JP (2) | JP6018081B2 (enExample) |
| KR (1) | KR101900664B1 (enExample) |
| ES (1) | ES2479544T1 (enExample) |
| WO (1) | WO2012095743A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060045872A1 (en) | 2004-08-25 | 2006-03-02 | Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco | Use of adipose tissue-derived stromal stem cells in treating fistula |
| SG10202001007TA (en) | 2005-09-23 | 2020-03-30 | Tigenix Sau | Cell populations having immunoregulatory activity, method for isolation and uses |
| US20160120910A1 (en) * | 2013-06-25 | 2016-05-05 | Tigenix S.A.U. | Cell populations having immunoregulatory activity, methods for the preparation and uses thereof |
| US20150104470A1 (en) * | 2013-10-11 | 2015-04-16 | Neil H. Riordan | Immune modulation by peri-lymphatic or intra-lymphatic cell therapy |
| US20170121685A1 (en) * | 2015-11-02 | 2017-05-04 | Tigenix S.A.U. | Mesenchymal stem cell-derived exosomes and their uses |
| GB201604304D0 (en) | 2016-03-14 | 2016-04-27 | Tigenix S A U | Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease |
| KR20190018420A (ko) * | 2016-05-06 | 2019-02-22 | 각코우호징 오사카 이카야쿠카 다이가쿠 | 염증성 질환 치료용 줄기세포의 기능 강화를 위한 스타틴 봉입 나노입자 제제, 및 이를 함유하는 염증성 질환 치료용 기능 강화 줄기세포 |
| JP6788003B2 (ja) * | 2016-08-26 | 2020-11-18 | 学校法人大阪医科薬科大学 | スタチン封入ナノ粒子を含有する機能増強幹細胞を含む炎症性疾患治療用細胞製剤 |
| WO2021075525A1 (ja) | 2019-10-17 | 2021-04-22 | テルモ株式会社 | 炎症性疾患を処置するための細胞培養物 |
| WO2021207192A1 (en) * | 2020-04-08 | 2021-10-14 | Figene, Llc | Methods and compositions for allergy and asthma treatment using fibroblasts |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9694038B2 (en) * | 2000-04-06 | 2017-07-04 | Wayne P. Franco | Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs |
| US20040115216A1 (en) * | 2002-07-12 | 2004-06-17 | The Johns Hopkins University | Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| CA2564679C (en) * | 2004-03-22 | 2015-06-23 | Osiris Therapeutics, Inc. | Mesenchymal stem cells and uses therefor |
| WO2005097147A1 (en) * | 2004-03-30 | 2005-10-20 | Boston Scientific Limited (Incorporated In Ireland) | Restenosis therapy using mesenchymal stem cells |
| US20060045872A1 (en) | 2004-08-25 | 2006-03-02 | Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco | Use of adipose tissue-derived stromal stem cells in treating fistula |
| SG10202001007TA (en) * | 2005-09-23 | 2020-03-30 | Tigenix Sau | Cell populations having immunoregulatory activity, method for isolation and uses |
| EP2303293A1 (en) * | 2008-05-27 | 2011-04-06 | Pluristem Ltd. | Methods of treating inflammatory colon diseases |
| GB0814249D0 (en) * | 2008-08-04 | 2008-09-10 | Cellerix Sa | Uses of mesenchymal stem cells |
| CN107090437A (zh) * | 2009-03-06 | 2017-08-25 | 国立大学法人三重大学 | 用于增强t细胞功能的方法 |
| HUE031921T2 (en) * | 2009-07-09 | 2017-08-28 | Tigenix S A U | Methods and preparations for use in cell therapy |
| WO2011047345A2 (en) * | 2009-10-15 | 2011-04-21 | Tai June Yoo | Methods of treating diseases of conditions using mesenchymal stem cells |
-
2012
- 2012-01-12 JP JP2013548903A patent/JP6018081B2/ja not_active Expired - Fee Related
- 2012-01-12 WO PCT/IB2012/000097 patent/WO2012095743A2/en not_active Ceased
- 2012-01-12 KR KR1020137021276A patent/KR101900664B1/ko not_active Expired - Fee Related
- 2012-01-12 US US13/979,308 patent/US20140154274A1/en not_active Abandoned
- 2012-01-12 EP EP12701941.2A patent/EP2663316A2/en not_active Ceased
- 2012-01-12 ES ES12701941.2T patent/ES2479544T1/es active Pending
-
2016
- 2016-09-29 JP JP2016190665A patent/JP2017035094A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Huang et al. | Potential therapeutic strategies for skeletal muscle atrophy | |
| Kircheis et al. | NF-κB pathway as a potential target for treatment of critical stage COVID-19 patients | |
| Fernandez-Francos et al. | Mesenchymal stem cell-based therapy as an alternative to the treatment of acute respiratory distress syndrome: current evidence and future perspectives | |
| Marchezan et al. | Immunological dysfunction in autism spectrum disorder: a potential target for therapy | |
| Trompette et al. | Dietary fiber confers protection against flu by shaping Ly6c− patrolling monocyte hematopoiesis and CD8+ T cell metabolism | |
| JP2012532859A5 (enExample) | ||
| Wang et al. | Regulation of inflammatory cytokine storms by mesenchymal stem cells | |
| Kulakova et al. | The contribution of macrophage plasticity to inflammatory arthritis and their potential as therapeutic targets | |
| Wang et al. | Honeysuckle‐derived nanovesicles regulate gut microbiota for the treatment of inflammatory bowel disease | |
| Liu et al. | Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis | |
| ES2479544T1 (es) | Células madre mesenquimales derivadas de tejido adiposo para administración intralinfática en enfermedades autoimmunes e inflamatorias | |
| Cai et al. | Mesenchymal stem cells and their exocytotic vesicles | |
| RU2012104529A (ru) | Способы и композиции для применения в клеточной терапии | |
| Wu et al. | Current understanding of mesenchymal stem cells in liver diseases | |
| Harrell et al. | Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS‐CoV‐2‐Induced Acute Respiratory Distress Syndrome | |
| Nam et al. | Intraperitoneal infusion of mesenchymal stem cell attenuates severity of collagen antibody induced arthritis | |
| Gu et al. | Endothelium‐derived engineered extracellular vesicles protect the pulmonary endothelial barrier in acute lung injury | |
| JP2015517488A5 (enExample) | ||
| BR112014010417A2 (pt) | Métodos para o tratamento de cânceres com o uso de formulações orais de análogos de citidina | |
| Gardin et al. | Could mesenchymal stem cell-derived exosomes be a therapeutic option for critically Ill COVID-19 patients? | |
| Fang et al. | Mechanisms of potential therapeutic utilization of mesenchymal stem cells in COVID-19 treatment | |
| JP2015502135A5 (enExample) | ||
| Koseoglu | New treatment modalities in Alzheimer's disease | |
| Shi et al. | Mesenchymal stem cells and connective tissue diseases: From bench to bedside | |
| Chen et al. | Decoding tumor-fibrosis interplay: mechanisms, impact on progression, and innovative therapeutic strategies |